StockWatch
·
SUPREME PETROCHEM LTD. · QQ2 FY-2027 · THE CALL

Strong volume recovery, margin compression raises execution risk

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsSPLPETROSUPREME PETROCHEM LTD.02 Nov 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Met capex commitment; PES/ABS ramp visible. Prior 8-10% volume guidance abandoned Q1, now recovered (+24% Q2). EBITDA margin comment 'will compress' proven true.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Q2 shows strong YoY growth (+77.5% revenue, +100% PAT) and recovery from Q1 volume slump (-24.5%). However, QoQ margin collapse (PAT -59%, NPM 4.9% vs H1 9.08%) and raw material volatility (styrene +83% since prior year) signal near-term execution risk. Capex pipeline (₹450 Cr) is credible but multi-year; near-term hinges on geopolitical stability and freight normalization.

₹1983.5 Cr

Revenue · +77.5% YoY

₹97.1 Cr

Reported PAT · +100.4% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Q2 operating income ₹1,957 Cr vs ₹1,100 Cr YoY

MET

Delivered Q2 revenue ₹1,983.5 Cr; YoY growth 77.5%

Q2 PAT ₹95 Cr with margins compressing as raw material prices normalize

MET

Delivered PAT ₹97.1 Cr (4.9% margin); vs H1 9.08%, confirms compression

Q2 volumes +24% YoY, +35% QoQ; H1 volumes -3% YoY despite Q2 rebound

MET

Q2 volume 95,242 MT; H1 176,085 MT (Q1 implied ~80,843 MT down from prior 181,000 MT)

ABS 85% utilized; equipment damage limits to 65% of rated capacity

MET

Management states using 85% of truncated capacity; repair timeline unspecified

H1 PAT ₹331 Cr implies Q1 PAT ~₹234 Cr; Q2 at ₹97 Cr shows -59% QoQ decline

MET

Delivered H1 data not disclosed; Q2 at ₹97.1 Cr implies Q1 ~₹237 Cr (Q2 -59% QoQ)

Earnings quality

What changed since the last call

Deltas vs. the prior call

Volume recovery momentum

Upgrade

Q1 -24.5% → Q2 +24% YoY; H1 still -3% but trajectory positive

Margin trajectory dampened

Downgrade

Q2 NPM 4.9% vs H1 9.08%; raw material cost pass-through incomplete; prior guidance 'margins will compress' proving accurate

Export headwinds persisting

Maintained

H1 export decline; Q2 shows some non-OEM recovery but still subdued; freight/geopolitical overhang ongoing

Capex execution on track

Maintained

₹450 Cr budget reaffirmed; ABS phase-1 ~70k tons, phase-2 80k tons by Q3 FY28; XPS Q1 FY28; no budget/timeline revisions

Specialty mix uplift

Upgrade

Specialty compounds 30–35% → 40% of mix; PES/ABS volumes 11.7k MT in H1 vs 4.3k MT prior year (+172%)

The Q&A

Q&A was professional and probing (10+ analysts). Management deflected on near-term margin normalization ('depends on macro') and geopolitical recovery ('very difficult to predict'). No pushback on capex; analysts focused on margin sustainability (Santosh Keshri), application ramp timing (Nirav Jimudia), and supply-chain disruption recovery (Nia Jain). Management held firm on hedged outlook but offered concrete operating metrics.

The exchanges that mattered

Volume growth trajectory — Aditya Khetan, SMIFS Institutional Equities

Partial

Volume growth contingent on US elections outcome & raw material availability. If normal post-elections & war clouds settle, YoY growth likely. ABS phase-1 70k tons by Q3 FY28; currently 65% of rated capacity; 85% of truncated capacity utilized. Not providing FY27–28 targets.

Compounding expansion — Nirav Jimudia, Anvil Wealth

Answered

80k tons by Q3 FY28. Targeting all applications including auto components, batteries, appliances. Already present in battery segment with acceptance. Full capacity (1.4L MT net) buildout by FY29–30. Initial traction on auto two-wheeler/mobility.

Raw material cost pass-through — Sailesh Raja, 360 ONE Capital

Answered

Inventory mainly raw material (SAP marks to market). Ongoing consumption throughout month; prices $900→$1,650 so carry-cost is real, expected in October month-end consumption. Spreads GIPS $200–250, HIPS $300–350 in Q2.

Margin recovery timing — Santosh Keshri, SKK HUF

Partial

No crystal ball. Changing global environment, geopolitical difficult to project. If US elections stabilize, war clouds settle, raw material availability eases, everything fine. Otherwise margin constraints continue. October demand good so far; but unpredictable.

Spreads & import dynamics — Rahul Agarwal, Ikigai Asset

Answered

Q2 spreads GIPS $200–250, HIPS $300–350 after freight/costs. Imports May–July higher due to duty exemption; now normalizing. Polystyrene India demand ~375k tons; we have ~60% market share; targeting applications exports.

Non-OEM vs OEM demand — Ansh Khimavat, Capital One

Answered

Q2 both OEM & non-OEM good. Split almost 50–50. First quarter non-OEM subdued & imports big due to duty exemption. Second quarter non-OEM back into market; demand strong.

Export recovery outlook — Nia Jain, Individual Investor

Partial

Exports difficult due to volatile raw material prices, freight rates, order-to-shipment timing gap. Need alternate supply sources to cover exports. Once markets normal, restarting exports not difficult; customers engaged. Currently volatile environment; difficult to encash opportunities regularly.

XPS capacity ramp & demand — Shiok Singhvi, Individual Investor

Answered

Commercial production Q1 FY27–28; capacity ramp over time. Full capacity 1.5L cubic meters expected absorbed 24–30 months in market. Currently 1.4L MT net sales; spreads $200–250 for GIPS. Targeting appliance & auto segments.

EPS market & applications — Nirav Jimudia, Annual Wealth

Partial

No EPS plant closures heard in Europe despite restructuring. India EPS demand 1.65L–1.7L tons total. No new EPS applications materializing recently; growth from existing applications (AC, appliances). Geopolitical disruption opportunities hard to execute given freight/raw material constraints.

Xmold growth & inorganic expansion — Rakesh Nayak, Individual Investor

Answered

Xmold doing good; numbers almost doubled YoY & YoY almost doubled. No inorganic growth at moment. ABS is most capital-intensive expansion focus internally; that is priority.

Guidance

Forward guidance and management's confidence

No FY27 quantified revenue target

Low

Prior 8–10% volume CAGR abandoned after Q1 -24.5% decline. Now growth dependent on US elections, raw material normalization, export recovery.

Polystyrene India demand ~375k tons; 60% market share targeting

Medium

Market backdrop good; management targeting appliance/AC boom exports. But no FY27 revenue number committed.

XPS full capacity (150k m³) absorbed 24–30 months post Q1 FY28 launch

Medium

Ramp timeline provided; demand from appliance/insulation segments; no revenue ₹ stated.

Margins will compress as raw material delta normalizes (prior call)

High

Q2 delivers: NPM 4.9% vs H1 9.08%. Guidance proving accurate; no recovery target set.

Gross margin dependent on styrene monomer pricing & freight normalization

Medium

Spreads GIPS $200–250, HIPS $300–350 in Q2; ranges contingent on macro. No margin floor/target.

EBITDA margin to remain volatile pending raw material stabilization

Medium

H1 EBITDA 13.9%, Q2 only 8.12%; management hedges 'very difficult to predict' near-term margin path.

₹450 Cr capex (ABS by June 2027, Polystyrene by Dec 2028)

High

Internally funded; debt-free status maintained. Reaffirmed in Q2 call; on-track execution visible (ABS phase-1 70k tons by Q3 FY28).

Risks the call surfaced

Ranked by how much they should concern a holder

Raw material volatility

High

Styrene monomer doubled $900→$1,650+; inventory marked to market but carry-cost lags; margin compression evident (Q2 NPM 4.9% vs 9.08% H1)

Export headwinds

High

H1 export volumes down despite Q2 rebound; ocean freight spike, limited styrene monomer availability, geopolitical disruption. Export recovery timeline 'very difficult to predict' per management.

Capex execution risk

Medium

ABS line equipment damage (currently 65% of rated capacity, 85% of truncated utilized); phase-1 ramp to 70k tons by Q3 FY28, phase-2 to 80k tons critical. Delay impacts revenue ramp & capex ROI.

Geopolitical dependency

Medium

Management explicitly caveating Q3–Q4 FY27 outlook on US elections, war clouds, shipping normalization. No quantified guidance; hedged commentary limits visibility; Q2 demand cited as good but 'very difficult to predict'.

Competitive capacity

Medium

New ABS capacity coming from competitors; duty-free imports of PS/ABS from ASEAN/China in Q2 pressured domestic pricing. Duty exemption ended July but competitors may follow with own capacity; domestic market share erosion risk.

Management

Score 7/10. Transparent on challenges (raw material volatility, export headwinds, geopolitical risk). Specific on capex timeline & capacity numbers. But hedged & vague on FY27 revenue/margin targets; caveated all forward guidance with 'very difficult to predict'. Capex on-track (₹450 Cr, ABS phase-1 70k MT by Q3 FY28, XPS Q1 FY28). PES/ABS ramp visible (+172% in H1). Xmold integration successful. Prior 8–10% volume guidance abandoned in Q1 (oversized initially), Q2 rebounded +24%.

What to watch next
  • 1 · Q3 FY27 (Sep–Dec 2026)

    US midterm elections; geopolitical risk reset; export demand recovery potential

  • 2 · Q3 FY28 (Sep–Dec 2027)

    ABS phase-1 ramp completion; capacity utilization rises toward breakeven

  • 3 · Q1 FY28 (Apr–Jun 2027)

    XPS insulation board commercial production launch; 150k m³ capacity

Capex pipeline (₹450 Cr) is credible but multi-year; near-term hinges on geopolitical stability and freight normalization.

Informational and educational content only. Not investment advice.